Usana Health Sciences Inc (USNA) financials
Usana Health Sciences revenue and earnings by year
Usana Health Sciences's revenue was $925 million in the fiscal year to January 3, 2026, up 8.3% from the year before. Net income was $10.8 million, 1.2% of revenue. Since the fiscal year to December 31, 2016, revenue has shrunk 0.9% a year on average.
Fiscal years, each labelled by the calendar year it ended in.
Income statement, the last 10 fiscal years
| Fiscal year to | Jan 2026 | Dec 2024 | Dec 2023 | Dec 2022 | Jan 2022 | Jan 2021 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 0.93 | 0.85 | 0.92 | 1.00 | 1.19 | 1.13 | 1.06 | 1.19 | 1.05 | 1.01 |
| Revenue growth | 8.3% | -7.2% | -7.8% | -15.8% | 4.6% | 7.0% | -10.8% | 13.6% | 4.1% | — |
| Gross profit | 0.72 | 0.69 | 0.74 | 0.80 | 0.97 | 0.93 | 0.87 | 0.99 | 0.87 | 0.83 |
| Gross margin | 78.3% | 81.1% | 80.8% | 80.6% | 81.6% | 81.6% | 82.3% | 83.1% | 82.9% | 82.1% |
| Operating income | 0.04 | 0.07 | 0.09 | 0.11 | 0.17 | 0.18 | 0.15 | 0.19 | 0.13 | 0.14 |
| Operating margin | 4.0% | 7.8% | 10.1% | 10.8% | 14.3% | 15.6% | 13.8% | 15.8% | 12.7% | 13.8% |
| Net income | 0.01 | 0.04 | 0.06 | 0.07 | 0.12 | 0.12 | 0.10 | 0.13 | 0.06 | 0.10 |
| Net margin | 1.2% | 4.9% | 6.9% | 6.9% | 9.8% | 11.0% | 9.5% | 10.6% | 6.0% | 9.9% |
| Diluted EPS | $0.58 | $2.19 | $3.30 | $3.59 | $5.73 | $5.86 | $4.42 | $5.11 | $2.52 | $3.99 |
| Free cash flow | 0.01 | 0.05 | 0.06 | 0.09 | 0.11 | 0.15 | 0.11 | 0.14 | 0.11 | 0.10 |
Diluted EPS is stated in today's shares (adjusted for every split since). Quarterly statements and the income statement as a flow chart are in the app: open USNA in Markets.
How Usana Health Sciences makes money
Revenue by segment in the quarter to April 4, 2026, as the company reports it.
| Segment | Revenue | Share |
|---|---|---|
| Core Nutritional | $204M | 81.7% |
| Hiya | $32.1M | 12.8% |
| Rise | $13.7M | 5.5% |
See also: USNA valuation and P/E history · USNA returns
No forecast, no recommendation. This page describes Usana Health Sciences Inc from published data; it is not advice to buy, sell or hold any security.
Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.